image
Viridian Therapeutics, Inc. VRDN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 12.29
-8.31 %
$ 1 B
Market Cap
-3.92
P/E
BALANCE SHEET
742 M ASSETS
51.38%
Growth Rates
1Year 51.38%
3Years 53.89%
5Years 89.65%
7Years 46.01%
10Years 57.14%
70.8 M LIABILITIES
46.20%
Growth Rates
1Year 46.20%
3Years 64.17%
5Years 37.29%
7Years 26.08%
10Years 42.17%
672 M EQUITY
51.95%
Growth Rates
1Year 51.95%
3Years 52.95%
5Years 111.81%
7Years 50.44%
10Years 60.31%
BALANCE SHEET DECOMPOSITION
Balance Sheet Viridian Therapeutics, Inc.
image
Current Assets 738 M
Cash & Short-Term Investments 718 M
Receivables 0
Other Current Assets 20.9 M
Non-Current Assets 3.94 M
Long-Term Investments 0
PP&E 3.44 M
Other Non-Current Assets 501 K
96.66 %2.81 %Total Assets$742.4m
Current Liabilities 47.9 M
Accounts Payable 2.14 M
Short-Term Debt 0
Other Current Liabilities 45.7 M
Non-Current Liabilities 22.9 M
Long-Term Debt 20.6 M
Other Non-Current Liabilities 2.31 M
3.03 %64.62 %29.09 %3.26 %Total Liabilities$70.8m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 99.6 102.8 155.6 42.3 45.9 24.8 32.6 47.4 3.3 10.8 5.1 0.2 0.1
Short Term Investments 618.0 374.5 269.0 154.7 81.7 2.0 29.9 0 0 0 0 0 0
Receivables 0 0.1 0.1 0.5 0 0.1 24 K 1.5 0.5 0.4 1.1 1.0 1.2
Inventory 0 0 (6.6) 0 0 0 0 0 64 K 0.2 0.2 0.4 0.2
Other Current Assets 20.9 9.0 6.5 2.6 2.0 5.4 5.2 4.8 0.3 0.6 0.4 0.5 0.2
Total Current Assets 738.5 486.5 424.6 200.2 129.6 29.7 65.4 51.9 4.3 11.7 6.8 2.1 1.7
PP&E 3.4 3.3 2.9 2.1 0.8 0.5 0.7 0.6 0.6 1.2 1.2 0.9 1.1
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0.5 0.6 7.6 1.5 0.9 (0.5) 50 K 50 K 0.3 15 K 90 K 0.7 45.6 K
Other Assets 0 0 0 0 0 0 0 0 (0.9) 0 0 0 0
Total Assets 742.4 490.4 435.1 203.7 131.3 30.3 66.1 52.5 4.3 12.9 8.1 3.7 2.8
LIABILITIES
Accounts Payable 2.1 2.2 14.2 2.3 0.7 1.1 0.6 0.9 0.2 0.2 0.3 100 K 26.7 K
Short Term Debt 0 0.8 0.6 0.5 0.5 4.0 2.3 0 0 1.1 80 K 0.7 22.6
Other Current Liabilities 45.4 23.3 18.2 10.5 9.2 5.1 3.9 3.0 4.4 1.1 1.7 0.5 1.0
Total Current Liabilities 47.9 26.6 33.3 13.6 10.7 10.2 6.7 3.9 4.6 2.5 2.0 1.4 23.6
Long Term Debt 20.6 20.2 4.6 0 0 4.3 8.0 9.9 2.8 0 0 0 42 K
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 2.0 1.0 1.2 1.2 0.5 0 66 K 0.2 0 24 K 0.1 0.3 0.6
Total Liabilities 70.8 48.4 40.0 16.0 11.2 14.5 14.8 14.0 4.6 2.5 2.1 1.6 24.2
EQUITY
Common Stock 0.8 0.5 0.4 0.2 42 K 0.3 0.3 0.2 7 K 0.1 38 K 27.9 K 0
Retained Earnings (995.9) (725.9) (488.2) (358.3) (278.9) (168.2) (126.3) (93.6) (30.6) (18.0) (6.6) (25.9) (21.4)
Other Accumulative Comprehensive Income/Loss 10 K 0.3 (0.4) (0.2) 8 K 0 3 K (2.8) 0 (0.7) (0.6) (0.4) (0.3)
Total Equity 671.6 442.0 395.1 187.7 120.0 15.8 51.3 38.5 (0.3) 10.4 6.0 2.0 (21.4)
Total Liabilities and Equity 742.4 490.4 435.1 203.7 131.3 30.3 66.1 52.5 4.3 12.9 8.1 3.7 2.8
SHARES OUTSTANDING
Common Shares Outstanding 67.9 44.8 32.1 11.9 3.6 2.1 2.0 1.3 0.7 0.5 0.2 0.2 0.2